NCT04352699

Brief Summary

The French healthcare system has been strongly mobilized since the start of the Covid-19 epidemic to take care of patients with Covid-19. This should not overlook the fact that some treatments, surgeries and examinations of non-Covid-19 patients must imperatively be maintained according to the assessment of their risk-benefit balance. In context, it appears that this is not always the case. In addition to the necessary social containment measures, there are general limitations on patient access to the operating theater, neglecting the individual interest of naive non-Covid-19 patients. Certain studies which report a higher and earlier risk of death of undetected and ultimately operated Covid-19 patients has reinforced, as a precaution, the massive deprogramming of naive patients and the restrictive access of surgical care for all. We believe that this could lead to a risk of delayed treatments and renunciation of care for naive patients who should not be considered at risk a priori in the event of surgery. The individual clinical and local health context should be first considered for appropriate surgical decision-making. As such, the French Department of Health and Human Services (DGS) has given general guidelines regarding the maintenance of follow-up and care for non-Covid-19 patients in this context of containment and major mobilization of health care professionals to care for people with COVID. Surgeries which could not be postponed because of the patient's status or if their postponement exposed to a significant risk of loss of chance, if needed in the light of the recommendations issued by learned societies, were concerned. In this sense, the investigator have selected the naive Covid-19 patients from Nice Hospital who should benefit from elective or urgent urological surgeries, taking into account their individual risk and the territorial epidemic rate. Their rate of ICU stays following their surgery has been analysed and their surgical follow-up outcomes during the epidemic period evaluated, according to the anti-Covid-19 measures established in Nice Hospital by comparing them to an earlier period without Covid-19.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 14, 2020

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 17, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 20, 2020

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
Last Updated

May 15, 2020

Status Verified

April 1, 2020

Enrollment Period

1 month

First QC Date

April 14, 2020

Last Update Submit

May 14, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of UCI admission for surgery-related complication

    Admission Rate is defined by the number of patient admitted to ICU due to surgical-related complication during 1 month and a half included in the Covid-19 period out of the number of operated patient in the same time within the institution

    1 month and a half

Secondary Outcomes (2)

  • Rate of surgery-specific death

    1 month and a half

  • Rate of coronaviruse positive serologies

    1 month and a half

Study Arms (1)

Naive patients

Group of naive patients who have undergone elective or emergency surgery during the study period

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient selected for elective surgery or emergency surgery in the time frame

You may qualify if:

  • naive patient for elective or emergency urological surgery

You may not qualify if:

  • minor less than 18 year old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nice

Nice, 06300, France

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 14, 2020

First Posted

April 20, 2020

Study Start

March 15, 2020

Primary Completion

April 17, 2020

Study Completion

May 1, 2020

Last Updated

May 15, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

no data sharing plan has been established

Locations